CA
NZ
UK
AU
IND
US
…
Core One Labs Inc. operates as a psychedelic research and development company. The company focuses on providing psychedelic medicines to novel delivery systems and psychedelic assisted psychotherapy; and intends to further develop and apply the technology to psychedelic compounds, such as psilocybin. It also provides natural health products; news dissemination services; financing services; and operates medical clinics, as well as engages in micro cultivation. The company was formerly known as Lifestyle Delivery Systems Inc. and changed its name to Core One Labs Inc. in September 2019. Core One Labs Inc. was incorporated in 2010 and is headquartered in Vancouver, Canada.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Public information on Core One Labs Inc (CLABF) is limited and available filings do not provide a clear, up-to-date description of its core operations or strategy. Long-term growth drivers therefore cannot be confirmed and would depend on the company's future disclosures, operational execution, and access to capital; the stock may appeal to investors seeking speculative microcap opportunities if management provides transparent, consistent reporting.
Material risks include limited or outdated disclosure, low trading liquidity on the Pink market, uncertain or unaudited financial reporting, and significant execution and financing risk.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2023-03-31 | 2022-12-31 | 2022-03-31 | 2021-12-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-03-31 | 2022-12-31 | 2022-03-31 | 2021-12-31 | 2021-03-31 |
| Income before tax | -15.98M | - | -37.05M | -37.05M | -46.90M |
| Minority interest | - | - | -0.01M | 0.00M | 0.18M |
| Net income | -15.98M | - | -37.05M | -37.05M | -54.62M |
| Selling general administrative | 7.03M | - | 8.36M | 12.07M | 5.47M |
| Selling and marketing expenses | - | - | 3.71M | - | 1.03M |
| Gross profit | 0.42M | - | 0.39M | - | 0.29M |
| Reconciled depreciation | 0.06M | - | 0.04M | 0.04M | 6.71M |
| Ebit | -7.84M | -7.92M | -12.17M | -12.25M | -6.73M |
| Ebitda | -7.80M | - | -12.13M | -36.99M | -6.52M |
| Depreciation and amortization | 0.04M | - | 0.04M | - | 0.21M |
| Operating income | -7.84M | - | -12.17M | -12.21M | -6.52M |
| Other operating expenses | 8.30M | - | 12.64M | - | 7.14M |
| Interest expense | 0.00M | - | 0.02M | 0.02M | 0.02M |
| Net interest income | -0.01M | - | -0.02M | -0.02M | -0.02M |
| Income tax expense | 0.00M | - | 0.06M | - | 7.71M |
| Total revenue | 0.46M | - | 0.43M | 0.43M | 2.91M |
| Total operating expenses | 8.25M | - | 12.64M | 12.64M | 7.14M |
| Cost of revenue | 0.04M | - | 0.04M | - | 2.63M |
| Total other income expense net | -8.14M | - | -24.82M | -24.82M | -39.75M |
| Discontinued operations | - | - | - | - | -7.90M |
| Net income from continuing ops | -14.56M | - | -37.05M | -37.05M | -46.90M |
| Net income applicable to common shares | -15.98M | -15.98M | -37.05M | -37.05M | -54.62M |
| Breakdown | 2023-03-31 | 2022-12-31 | 2022-03-31 | 2021-12-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-03-31 | 2022-12-31 | 2022-03-31 | 2021-12-31 | 2021-03-31 |
| Total assets | 8.11M | - | 7.61M | 7.61M | 9.52M |
| Intangible assets | - | - | 5.70M | 5.70M | 4.09M |
| Other current assets | 0.21M | 0.03M | 0.07M | 0.03M | 0.09M |
| Total liab | 1.40M | - | 3.30M | 3.30M | 4.13M |
| Total stockholder equity | 6.72M | - | 4.31M | 4.31M | 5.39M |
| Other current liab | 0.05M | 0.16M | -1.32M | 0.55M | -0.45M |
| Common stock | 150.83M | 146.42M | 127.54M | 127.54M | 97.18M |
| Capital stock | - | - | 127.54M | 127.54M | 97.18M |
| Retained earnings | -164.64M | -160.64M | -144.67M | -144.67M | -106.51M |
| Good will | 0.59M | - | 0.59M | 0.59M | 0.00M |
| Other assets | 0.00M | - | - | - | - |
| Cash | 0.63M | - | 0.76M | 0.76M | 0.53M |
| Total current liabilities | 1.40M | 1.41M | 3.30M | 3.30M | 3.70M |
| Net debt | -0.63M | - | -0.73M | - | -0.10M |
| Short term debt | - | - | 0.03M | - | - |
| Short long term debt | - | - | 0.03M | 0.03M | - |
| Short long term debt total | - | - | 0.03M | - | 0.43M |
| Other stockholder equity | 20.72M | -0.22M | 21.72M | -0.29M | 14.80M |
| Property plant equipment | 0.12M | 0.12M | 0.15M | 0.15M | 0.45M |
| Total current assets | 1.13M | 1.95M | 1.16M | 1.16M | 4.99M |
| Net tangible assets | 0.66M | 0.66M | -1.98M | -1.98M | 1.30M |
| Short term investments | 0.11M | - | 0.11M | 0.11M | 1.37M |
| Net receivables | 0.18M | 0.13M | 0.21M | 0.19M | 3.00M |
| Long term debt | - | - | - | - | 0.43M |
| Inventory | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Accounts payable | 0.67M | 0.76M | 2.30M | 2.30M | 2.08M |
| Accumulated other comprehensive income | -0.19M | - | -0.29M | - | -0.08M |
| Non currrent assets other | 5.70M | - | - | - | - |
| Non current assets total | 6.98M | - | 6.45M | 6.45M | 4.54M |
| Capital lease obligations | - | - | - | - | 0.00M |
| Breakdown | 2023-03-31 | 2022-12-31 | 2022-03-31 | 2021-12-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-03-31 | 2022-12-31 | 2022-03-31 | 2021-12-31 | 2021-03-31 |
| Investments | 1.68M | - | 1.29M | 1.29M | -0.41M |
| Change to liabilities | 0.03M | 0.03M | 0.56M | 0.56M | 1.57M |
| Total cashflows from investing activities | 0.19M | 0.19M | 1.29M | 1.29M | -0.31M |
| Net borrowings | 0.35M | 0.35M | 0.35M | 0.35M | 0.46M |
| Total cash from financing activities | 2.40M | 2.61M | 3.58M | 3.58M | 4.43M |
| Change to operating activities | -0.21M | -0.21M | -0.03M | -0.03M | 0.44M |
| Net income | -15.98M | -15.98M | -37.05M | -37.05M | -46.90M |
| Change in cash | -0.14M | 0.80M | 0.23M | 0.23M | 0.41M |
| Begin period cash flow | 0.76M | 0.76M | 0.53M | 0.53M | 0.12M |
| End period cash flow | 0.63M | - | 0.76M | 0.76M | 0.53M |
| Total cash from operating activities | -2.77M | -2.00M | -4.64M | -4.64M | -2.32M |
| Issuance of capital stock | -0.03M | - | 3.58M | 3.58M | 3.97M |
| Depreciation | 0.04M | 0.05M | 0.04M | 0.04M | 0.04M |
| Dividends paid | - | - | - | - | 0.00M |
| Change to inventory | -0.00M | -0.00M | -0.00M | -0.00M | -0.00M |
| Change to account receivables | 0.07M | 0.06M | 1.27M | 1.27M | -0.03M |
| Other cashflows from financing activities | 0.14M | - | 1.29M | - | 0.01M |
| Change to netincome | 14.05M | 14.05M | 30.54M | 30.54M | 48.93M |
| Capital expenditures | 0.03M | 0.01M | 0.01M | 0.01M | 0.01M |
| Change in working capital | -2.62M | - | 1.80M | 1.80M | 1.98M |
| Stock based compensation | 4.04M | - | 5.98M | 5.98M | 2.17M |
| Other non cash items | 15.79M | - | 22.41M | 22.41M | 40.43M |
| Free cash flow | -2.80M | - | -4.65M | -4.65M | -2.32M |
Sector: Healthcare Industry: Biotechnology
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| NVO Novo Nordisk A/S |
0.80 2.03% |
39.94 | 41.58 | 31.15 | 2.13 | 32.99 | 2.11 | 4.70 |
| VRTX Vertex Pharmaceuticals Inc |
19.54 3.62% |
559.54 | 30.22 | 24.27 | 10.36 | 6.50 | 9.99 | 24.66 |
| REGN Regeneron Pharmaceuticals Inc |
93.31 11.40% |
912.08 | 29.07 | 20.12 | 7.57 | 3.82 | 6.95 | 19.42 |
| ARGNF argenx SE |
- -% |
900.30 | 45.77 | 31.25 | 13.84 | 7.12 | 11.38 | 36.06 |
Core One Labs Inc. operates as a psychedelic research and development company. The company focuses on providing psychedelic medicines to novel delivery systems and psychedelic assisted psychotherapy; and intends to further develop and apply the technology to psychedelic compounds, such as psilocybin. It also provides natural health products; news dissemination services; financing services; and operates medical clinics, as well as engages in micro cultivation. The company was formerly known as Lifestyle Delivery Systems Inc. and changed its name to Core One Labs Inc. in September 2019. Core One Labs Inc. was incorporated in 2010 and is headquartered in Vancouver, Canada.
| Name | Title | Year Born |
|---|---|---|
| Dr. Robert E. W. Hancock FRSC, OC, Ph.D. | Exec. Chairman | NA |
| Mr. Joel Shacker | CEO & Director | 1990 |
| Mr. Geoffrey Balderson | CFO, Sec. & Director | 1978 |
| Dr. Santiago Ferro | Chief Medical Officer | NA |
| Mr. Brad Paul Eckenweiler | Founder & Advisor | 1954 |
| Mr. Jan Burian Ph.D. | Chief Technical Officer | NA |
| Dr. Elizabeth Matthews | Head of Scientific & Regulatory Affairs | NA |
| Mr. Joel Shacker | CEO & Director | 1991 |
| Mr. Geoffrey Balderson | CFO, Secretary & Director | 1978 |
| Dr. Santiago Ferro | Chief Medical Officer & Director | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
-1.89%
Communication Services
-0.40%
Consumer Cyclical
-0.22%
Consumer Defensive
+0.33%
Energy
-0.12%
Financial Services
-0.79%
Financials
+2.35%
Healthcare
-1.57%
Industrials
-1.00%
Real Estate
-0.28%
Technology
-3.22%
Utilities
-0.27%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...